Muscular force is reduced in neurofibromatosis type 1

Journal of Musculoskeletal Neuronal Interactions

Volumn 9, Issue 1, 2009, Pages 15-17

  Souza, J F ^a   Passos, R L F ^a   Guedes, A C M ^a   Rezende, N A ^a   Rodrigues, Luis Oswaldo Carneiro ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Muscular force and handgrip; Neurofibromatosis Type 1

Indexed keywords

ADULT; AGE DISTRIBUTION; ARM CIRCUMFERENCE; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRIP STRENGTH; HUMAN; MALE; MUSCLE FORCE; MUSCLE FUNCTION; NEUROFIBROMATOSIS; PHYSICAL ACTIVITY; SEX DIFFERENCE; SITTING;

ADOLESCENT; ADULT; ANATOMY, CROSS-SECTIONAL; CHILD; FEMALE; FOREARM; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; NEUROFIBROMATOSIS 1; YOUNG ADULT;

EID: 67649418467     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Feldman R, Denecke J, Grenzebach G, Schuierer G, Weglage J. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities. Neurology 2003;61:1725-8.
2. Souza JF, Guedes ACM, Rodrigues, Rezende NA. Some under-reported clinical complications in NF1 patients. Annals of the 2008 NF Conference: genes to complications to treatments. The Children's Tumor Foundation. Bonita Springs, USA 2008; 140.
3. Stevenson DA, Moyer-Mileur LJ, Carey JC, Quick JL, Hoff CJ, Viskochil DH. Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography. J Musculoskeletal Neuronal Interact 2005;5:145-9.
4. Rantanen T, Guralnik JM, Foley D, Masaki K, Leveille S, Curb D, White L. Midlife handgrip strength as a predictor of old age disability. JAMA 1999;281:558-60.
5. Bruce SA, Phillips SK, Woledge RC. Interpreting the relation between force and cross-sectional area in human muscle. Med and Sci in Sports and Exerc 1995;27:235-41.
6. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A. Guidelines for the diagnosis and management of individuals with neurofibromatosis type 1. J Med Genet 2007;44:81-8.
7. Riccardi VM, Kleiner B. Neurofibromatosis: a neoplastic birth defect with two age peaks of severe problems. Birth defects: Original article series. The National Foundation 1977;13:131-8.
8. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985;66:69-72.
9. Clarke MSF. The effects of exercise on skeletal muscle in the aged. J Musculoskeletal Neuronal Interact 2004;4:175-8.
10. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, Nebiker M, Theiler R, Pfeifer M, Begerow B, Lew RA, Conzelmann M. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone and Min Res 2003;18:343-51.
11. Lammert M, Friedman JM, Roth HJ, Friedrich RE, Kluwe L, Atkins D, Schooler T, Mautner V-F. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet 2006;43:810-3.
12. Stevenson DA, Moyer-Milieur LJ, Murray M, Slater H, Sheng X, Carey JC, Dube B, Viscochil DH. Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 2007;150:83-8.
13. Hollick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
14. Ablon J. Gender Response to Neurofibromatosis 1. Soc Sci Med 1996;42:99-109.